Final Program [International Conference on AIDS (14th: 2002: Barcelona, Spain)]

Oral Sessions 0o:30o - 12:00

Wednesday july 1o

Empowerment PWAs: Involvement from Paper
G7 to Action
0 Oral Abstract Session
Venue: Hall 2:2
Date: Wednesday, July o10, 2002
Time: 10:30- 12:00
Chairs: Catherine Williams, Trinidad and Tobago
Vicente Miranda, Honduras
o10:30o WeOrG1291 Advocating for a legislation that protects
people living with HIV/AIDS (PWAs)
rights
R P U Pascal, V DS Deliyanis,
D M C Melendez, C B M Bustamante,
CS R Sdnchez, LY M Yaconi,
L 0 D Olivares (Chile)
o10:45 WeOrG1292 Meaningful involvement of people living
with HIV/AIDS: positive and negative
effects of involvement in communitybased programs
C JCastle1, C Cornu2, R Dua3,
D Herrera4, V NadkarnP,
A Ouedraogo5, N Velasco4
(United States; 2United Kingdom; 3/ndia;
4Ecuador; 5Burkina Faso)
11:00oo WeOrG1293 Tackling a crisis situation among rural
HIV positive women
A Ramaiah (India)
11:15 WeOrG1294 Greater involvement of people living with
HIV/AIDS in Namibia
R D Shipiki (Namibia)
11:30 WeOrG1295 Improved skills development for persons
living with HIV/AIDS and service
providers in Mexico and Canada
D Ibarra Brito', A I Luna-Cadena,
W O'Briain2, I G Cabrera-Resdndiz'
(Mexico; 2Canada)

[SYAO3immune Response to HIV

Venue:
Date:
Time:
Chairs:

Symposium Session
Hall 2:4
Wednesday, July o10, 2002
10:30 - 12:00
Nathan Clumeck, Belgium
Montserrat Plana, Spain

10: 0 WeOrA197
I.,,

Harnessing the immune system to fight
HIV infection
Bruce Walker (United States)

10:45 WeOrAi98 A novel approach unravels impaired
thymopoYesis during H IV infection
Remi Cheynier (Canada)
11:oo WeOrA199 New insights in immune reconstitution
Bri itte Autran (France)
11:15 WeOrA2oo Title to be announced
Richard Koup (United States)
11:30 WeOrA2ol Human neutralizing antibodies and
a vaccine for HIV-1
Dennis Burton (United States)
11:45 WeOrA2o2 The importance of CD8+, cell
noncytotoxic anti-HIV responses in
preventing infection and progression to
disease
Jay Levy (United States)
[SYD02, Vaccine Trials

Venue:
Date:
Time:
Chairs:

Symposium Session
Hall Verdi
Wednesday, July o10, 2002
10:30 - 12:oo00
Suphak Vanichseni, Thailand
Giovanni Rezza, Italy

11:45 WeOrG1296

Greater involvement of people living with
HIV and AIDS: key to successful AIDS
program
N L Ortega, G Gonzales, M Liwanag
(Philippines)

Wednesday

BS8
Venue:
Date:
Time:
Chairs:

MTCT: Room for Solutions

Bridging Session
Hall 1:2
Wednesday, July 1o, 2002
o10:30 - 12:o00
Allan Rosenfield, United States
Josep-Oriol Coil, Spain

10:30 WeOrD1297 Global need and current delivery
capacity for future HIV vaccines
M L Chang, MY Madrid, R Widdus,
P Ghys, N Walker, J Esparza (WHO)
o10:45 WeOrD1298 On the analysis of viral endpoints in HIV
vaccine trials
M G Hudgens, A Hoering, S G Self
(United States)
11:oo WeOrD1299 Conduct of the first phase III efficacy trial
of a preventive HIV-1 vaccine (AIDSVAX~
B/B) in North America and Europe
C Harrol, F]udson', S Brown',
R Coutinho2, V Popovic,
M Gurwith, Vaxoo4 Study Team1
(United States; 2The Netherlands)
11:15 WeOrD13oo00 Ongoing follow-up of injecting drug
users (IDUs) in the AIDSVAX~B/E
vaccine efficacy trial in Bangkok,
Thailand
K Choopanya,1I Tappero',
P Pitisuttithum', S Vanichseni,
D Kitayaporn, U Sangkum',
K Hiranrus, D Francis2
(Thailand; 2United States)
11:30 WeOrD13ol The demand for an HIV/AIDS vaccine
among high-risk groups: does risk
matter?
C Suraratdechal, M Ainsworth2,
V Tangcharoensathien'
(Thailand; 2United States)

o10:30o WeOrl93
o10:45 WeOr194
11:oo WeOrl95
11:15 WeOrl96

Effective strategies in resource
constrained settings
Jeffrey Strinqer (Zambia)
MTCT
Wafaa EI-Sadr (United States)
Non-ARV interventions
James Mclntyre (South Africa)
Scaling up
Siripon Kanshana (Thailand)

11:45 WeOrDl3o2

Minimizing regulatory delays in the
approval and licensure of new HIV/AIDS
vaccines
M T Isbell', R Widdus2, L Williams,
D Gold' (United States; 2Switzerland)

140 Final Program